Back to results
US 5,328,842 AGranted
Compounds, vectors and methods for expressing human, cytosolic phospholipase A.sub.2
AssigneeEli Lilly and Company
InventorsXue-Chiou C. Chiou, JoAnn Hoskins, Ruth M. Kramer, John D. Sharp, Donald L. White
Life of this patent
Estimating the term…
Abstract
The invention includes recombinant DNA compounds, vectors and methods useful for expressing an exceptionally rare, human, cytosolic phospholipase A.sub.2 (cPLA.sub.2) enzyme. The invention also includes a method for screening compounds to identify inhibitors of cPLA.sub.2 which is believed to partake in several disease processes.
Claims21
A gene consisting essentially of a recombinant DNA sequence that encodes a protein having the amino acid sequence of SEQ ID NO:2.
Dependencies are inferred from the claim text.